All research papers

General versus site specific quantile random forest models for virtual patient-specific quality assurance of VMAT plans.

Long-term stability evaluation of user-derived electrometer calibration factors (k_{elec, user}) for radiotherapy dosimetry.

Combined Maximum Tolerated Activity and Lesion-based Dosimetry for Personalized Radioiodine Therapy in Metastatic Differentiated Thyroid Carcinoma: An Early Institutional Experience.

Application of theranostics in thyroid cancer management.

Deep learning-based CNN method for fiducial marker detection in kilovoltage X-ray images for liver tumor motion monitoring.

Evaluation of neutron dose equivalent in prostate stereotactic body radiotherapy by bubble detector.

Evaluation of a Faraday cup-style detector as a beam diagnostic system for ultra-high dose rate (FLASH) electron beams.

Combining an α_vβ₆-Targeted ¹⁷⁷Lu-Based Peptide Receptor Radionuclide Therapy with Olaparib to Boost Therapeutic Efficacy in Pancreatic Cancer.

Maskless head and neck radiotherapy using surface-guided radiation therapy: initial clinical feasibility of real-time setup, intrafraction monitoring, and automatic beam-hold.

Stereotactic MRI-guided adaptive radiation therapy (SMART) for locally advanced pancreatic cancer: A prospective single-center cohort study.

Characterizing magnetic field coupling in MRI-guided radiotherapy by solving a dirichlet problem with sparsely sampled boundary conditions.

Stereotactic radiosurgery (SRS) for small cell lung cancer (SCLC) brain metastases: a real-world UK tertiary center experience.

Assessing the role of plan complexity and target geometry through multi-institutional gel based end-to-end QA in multi-focal single isocenter stereotactic radiosurgery.

Hippocampal Brain Metastases Treatment With Whole Brain Radiotherapy or Stereotactic Radiosurgery: A First Single Center Experience.

SRS/SBRT commissioning process with a hybrid beam data model in new preconfigured CyberKnife system.

Ultrafast proton delivery with pin ridge filters (pRFs): repurposing single-energy delivery for motion management in proton therapy.

MPLA case: A proposal for purchasing SRS/SBRT QA equipment.

Development and evaluation of a water-profile-based calibration method for 2D ionization chamber arrays in medical linear accelerator quality assurance.

Toward a Biopsy-Free Diagnosis of Prostate Cancer: Potential of Combined ¹⁸F-Flotufolastat PSMA PET and mpMRI.

Baseline Ga-68 PSMA PET/CT-derived volumetric parameters as predictors of biochemical recurrence following radical prostatectomy.

FAPI PET Reveals Active Fibroblast-Driven Remodeling Beyond Infarct Scar.

Outcome Prediction After [¹⁷⁷Lu]Lu-PSMA I&T in Metastatic Castration-Resistant Prostate Cancer: External Validation of a [⁶⁸Ga]Ga-PSMA-11 PET-Based Model with [¹⁸F]F-Flotufolastat.

Cross-section measurements of lanthanum radioisotopes towards an optimized production of 133La and 135La for theranostic applications.

Local control after stereotactic radiation for thyroid cancer: a histology risk-stratified analysis.

Two-year dynamic risk stratification and adjuvant radioiodine efficacy in initial non-distant metastatic papillary thyroid carcinoma harboring TERT promoter mutations.

Radioiodine-induced cGAS-STING signaling and antitumor immunity in thyroid cancer.

Intra-adaptational motion during online adaptive radiotherapy: analysis of couch shifts and implications for margin design.

Technical and biological validation of prostate apparent diffusion coefficient measurements on an MRI-linac.

Radiosurgery for Spetzler-Martin Grade III Arteriovenous Malformations of the Brain. Comparison of the Results of a Single Institution in Finland with a Systematic Literature Review.

Second Primary Malignancy Risk Following Radioactive Iodine Therapy for Thyroid Cancer: A Population-based Matched Cohort Study in Taiwan.

DSDFF-YOLO: an automated computer-aided diagnostic method for post-therapy radioiodine whole-body scan.

Fully Automated Segmentation of [¹⁸F]FDG and [⁶⁸Ga]/[¹⁸F]PSMA PET/CT Images via Data-Centric Deep Learning.

Systematic PEGylation optimization of Dar3A-based FAP-targeted PET probes and first-in-human study.

[¹⁷⁷Lu]Lu-DOTATATE Molecular Radiotherapy During Induction Chemotherapy for First-Line Stage 4 High-Risk Neuroblastoma in South African Children: Protocol for a Phase 1 Randomized Controlled Trial (LuDO-SA Trial).

Clinical Imaging of ²²⁵Ac in a PET Scanner via Time-of-Flight Cascade γ-Ray Imaging.

Monte Carlo evaluation of a novel hybrid-shielded gamma probe with integrated counting and emission direction-finding capabilities.

Surface-guided radiotherapy setup using an open-face mask for head and neck cancer; the OPEN trial approach.

Comparison of deformable image registration algorithms for planning CT and CBCT in prostate cancer patients treated with external beam radiation therapy.

Single-arm, multicentre phase II trial of sintilimab plus platinum-based doublet chemotherapy followed by adaptive radiotherapy strategy for patients with unresectable stage III non-small-cell lung cancer in China: the ART-LUNG 01 study protocol.

Evaluation of cases with over 10 years of follow-up after stereotactic body radiotherapy for Stage I lung cancer.

Bridging the PSMA PET/CT access gap in prostate cancer: evidence, barriers, and priorities for implementation.

Theranostics in the management of prostate cancer: from concept to clinical practice.

Preliminary results of the STARLORD study: a mono-institutional prospective phase II experience of STereotActic Radiotherapy for LOcally advanced non small cell lung cancer ineligible for concurrent chemoRaDiation.

Somatostatin Receptor Expression and Theranostic Applications Across Non-Neuroendocrine Tumors: A Molecular-to-Clinical Review.

Impact of magnetic field orientation and strength on dose distributions in 6 MV photon beams: A Monte Carlo study.

Optimizing IVIM measurement on magnetic resonance linear accelerator using multi-b-value acquisition and physics-informed neural network.

Dose to the Fetus in Pregnant Women Undergoing Stereotactic Radiosurgery for Brain Tumors.

Clinical utility of endorectal balloons in prostate cancer external beam radiotherapy: a systematic review and meta-analysis.

Clinical outcomes and blood-based biomarkers across two SABR-treated metastatic settings: oligoprogression under immune checkpoint inhibition and oligometastatic disease.

The impact of RET fusions on radioiodine avidity and prognosis in patients with distant metastatic papillary thyroid cancer.

Stage migration in prostate cancer: the role of PSMA-PET in identifying oligometastatic disease.

Pembrolizumab and Peptide Receptor Radionuclide Therapy for Patients with Metastatic Well-Differentiated Neuroendocrine Tumors.

Prolonging breath-hold duration in radiotherapy using cognitive engagement.

Cone beam computed tomography guided online adaptive radiotherapy for cervical Cancer: Two-year single-Centre implementation and clinical experience.

Target-volume-based prescription selection for specified adverse-effect levels in automated stereotactic radiosurgery.

Optimization of a β probe for ¹⁸F radio-guided surgery.

Longitudinal radiomics of liver metastases during magnetic resonance-guided radiotherapy.

Population-based analysis of single-fraction versus multi-fraction stereotactic ablative radiotherapy for early-stage non-small cell lung cancer.

The clinical impact of 131-iodine whole-body scintigraphy following 131-iodine therapy of thyroid cancer.

Cross-section measurement of ¹⁶⁵Ho(d,x) reactions and comparison of deuteron and proton activation of holmium for¹⁶⁵Er production.